SEC
SlamSEC
SearchBrowseEarnings

Apellis Pharmaceuticals, Inc.

Nasdaq:APLS
Pharmaceutical Preparations·WALTHAM, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

17 shown
FiledDescription
7/1/25
1.01
Material Agreement
→
5/14/24
1.012.03
Material Agreement · New Debt Obligation
→
11/1/23
1.011.02
Material Agreement · Agreement Terminated
→
2/24/23
1.01
Material Agreement
→
8/2/22
1.01
Material Agreement
→
7/27/22
1.01
Material Agreement
→
↓ 11 more
CEO
Francois Cedric